念珠菌属侵袭性分离株的体外药敏情况：氟康唑敏感剂量依赖性光滑念珠菌分离株的比例迅速上升。
In vitro susceptibilities of invasive isolates of Candida species: rapid increase in rates of fluconazole susceptible-dose dependent Candida glabrata isolates.
作者信息
Ruan Sheng-Yuan, Chu Chen-Chen, Hsueh Po-Ren
机构信息
Department of Internal Medicine, National Taiwan University Hospital Yun-Lin Branch, Yun-Lin, Taiwan.
出版信息
Antimicrob Agents Chemother. 2008 Aug;52(8):2919-22. doi: 10.1128/AAC.00323-08. Epub 2008 May 5.
Abstract
Voriconazole, posaconazole, caspofungin, micafungin, and anidulafungin demonstrated potent in vitro activities against 286 invasive Candida isolates. Analysis of the fluconazole susceptibilities of 204 bloodstream Candida glabrata isolates revealed a rapid shift from susceptible (64% in 1999 to 2001 to 19% in 2007) to susceptible-dose dependent (27% in 1999 to 2001 and 75% in 2007).
摘要
伏立康唑、泊沙康唑、卡泊芬净、米卡芬净和阿尼芬净对286株侵袭性念珠菌分离株显示出强大的体外活性。对204株光滑念珠菌血流感染分离株的氟康唑敏感性分析显示，其敏感性迅速从敏感（1999年至2001年为64%，2007年为19%）转变为剂量依赖性敏感（1999年至2001年为27%，2007年为75%）。
相似文献
1
In vitro susceptibilities of invasive isolates of Candida species: rapid increase in rates of fluconazole susceptible-dose dependent Candida glabrata isolates.念珠菌属侵袭性分离株的体外药敏情况：氟康唑敏感剂量依赖性光滑念珠菌分离株的比例迅速上升。
Antimicrob Agents Chemother. 2008 Aug;52(8):2919-22. doi: 10.1128/AAC.00323-08. Epub 2008 May 5.
2
The activity of echinocandins, amphotericin B and voriconazole against fluconazole-susceptible and fluconazole-resistant Brazilian Candida glabrata isolates.棘白菌素类、两性霉素 B 和伏立康唑对氟康唑敏感和氟康唑耐药巴西光滑念珠菌分离株的活性。
Mem Inst Oswaldo Cruz. 2012 May;107(3):433-6. doi: 10.1590/s0074-02762012000300022.
3
Identification and antifungal susceptibility of Candida species isolated from bloodstream infections in Konya, Turkey.从土耳其科尼亚血流感染中分离出的念珠菌属的鉴定及抗真菌药敏性
Ann Clin Microbiol Antimicrob. 2016 May 31;15(1):36. doi: 10.1186/s12941-016-0153-1.
4
Changing epidemiology of candidaemia in Australia.澳大利亚念珠菌血症流行病学的变化
J Antimicrob Chemother. 2017 Apr 1;72(4):1103-1108. doi: 10.1093/jac/dkw422.
5
Prevalence and Antifungal Susceptibility of the Emerging Fungal Species, , Isolated in a Teaching Hospital in Poland.在波兰的一家教学医院中分离出的新兴真菌种 的流行情况和抗真菌药敏性。
Pol J Microbiol. 2019 Sep;68(3):303-308. doi: 10.33073/pjm-2019-032. Epub 2019 Sep 3.
6
Comparative effects of micafungin, caspofungin, and anidulafungin against a difficult-to-treat fungal opportunistic pathogen, Candida glabrata.比较米卡芬净、卡泊芬净和阿尼芬净对一种难以治疗的真菌性机会致病菌光滑念珠菌的疗效。
Antimicrob Agents Chemother. 2012 Mar;56(3):1215-22. doi: 10.1128/AAC.05872-11. Epub 2011 Dec 27.
7
Frequency of decreased susceptibility and resistance to echinocandins among fluconazole-resistant bloodstream isolates of Candida glabrata.氟康唑耐药近平滑念珠菌血流分离株对棘白菌素类药物敏感性降低和耐药性的频率。
J Clin Microbiol. 2012 Apr;50(4):1199-203. doi: 10.1128/JCM.06112-11. Epub 2012 Jan 25.
8
Synergistic activities of three triazoles with caspofungin against Candida glabrata isolates determined by time-kill, Etest, and disk diffusion methods.三种三唑类药物与卡泊芬净联合对光滑念珠菌分离株的协同作用，通过时间杀伤、Etest 和纸片扩散方法确定。
Antimicrob Agents Chemother. 2010 May;54(5):2244-7. doi: 10.1128/AAC.01527-09. Epub 2010 Mar 1.
9
Trends in species distribution and susceptibility of bloodstream isolates of Candida collected in Monterrey, Mexico, to seven antifungal agents: results of a 3-year (2004 to 2007) surveillance study.墨西哥蒙特雷收集的念珠菌血流分离株的物种分布及对七种抗真菌药物敏感性的趋势：一项为期三年（2004年至2007年）的监测研究结果
J Clin Microbiol. 2008 Sep;46(9):2902-5. doi: 10.1128/JCM.00937-08. Epub 2008 Jul 16.
10
Assessment of the in vitro kinetic activity of caspofungin against Candida glabrata.评估卡泊芬净对光滑念珠菌的体外动力学活性。
Antimicrob Agents Chemother. 2010 Jan;54(1):522-5. doi: 10.1128/AAC.01339-08. Epub 2009 Oct 19.
引用本文的文献
1
Epidemiology and antifungal susceptibility of candidemia isolates of non-albicans Candida species from cancer patients.非白念珠菌属念珠菌血症分离株的流行病学和抗真菌药敏性分析。
Emerg Microbes Infect. 2017 Oct 11;6(10):e87. doi: 10.1038/emi.2017.74.
2
Evaluation of miR-146a expression level in macrophages exposed to .暴露于……的巨噬细胞中miR-146a表达水平的评估 。
（注：原文中“exposed to”后面缺少具体内容）
Curr Med Mycol. 2016 Jun;2(2):16-19. doi: 10.18869/acadpub.cmm.2.2.6.
3
In Vitro Activities of Six Antifungal Drugs Against Candida glabrata Isolates: An Emerging Pathogen.六种抗真菌药物对光滑念珠菌分离株的体外活性：一种新兴病原体
Jundishapur J Microbiol. 2016 Apr 23;9(5):e36638. doi: 10.5812/jjm.36638. eCollection 2016 May.
4
Identification and antifungal susceptibility of Candida species isolated from bloodstream infections in Konya, Turkey.从土耳其科尼亚血流感染中分离出的念珠菌属的鉴定及抗真菌药敏性
Ann Clin Microbiol Antimicrob. 2016 May 31;15(1):36. doi: 10.1186/s12941-016-0153-1.
5
Systematic phenotyping of a large-scale Candida glabrata deletion collection reveals novel antifungal tolerance genes.对大规模光滑念珠菌缺失文库进行系统表型分析揭示了新的抗真菌耐受基因。
PLoS Pathog. 2014 Jun 19;10(6):e1004211. doi: 10.1371/journal.ppat.1004211. eCollection 2014 Jun.
6
Antifungal susceptibilities of Candida isolates causing bloodstream infections at a medical center in Taiwan, 2009-2010.2009 - 2010年台湾某医疗中心引起血流感染的念珠菌分离株的抗真菌药敏性
Antimicrob Agents Chemother. 2014 Jul;58(7):3814-9. doi: 10.1128/AAC.01035-13. Epub 2014 Apr 21.
7
Role of Dectin-2 for host defense against systemic infection with Candida glabrata.Dectin-2 在宿主防御光滑念珠菌全身感染中的作用。
Infect Immun. 2014 Mar;82(3):1064-73. doi: 10.1128/IAI.01189-13. Epub 2013 Dec 16.
8
Antifungal activity of fused Mannich ketones triggers an oxidative stress response and is Cap1-dependent in Candida albicans.融合曼尼希酮的抗真菌活性引发氧化应激反应，并依赖于白念珠菌中的 Cap1。
PLoS One. 2013 Apr 30;8(4):e62142. doi: 10.1371/journal.pone.0062142. Print 2013.
9
Fluconazole exposure rather than clonal spreading is correlated with the emergence of Candida glabrata with cross-resistance to triazole antifungal agents.氟康唑暴露而不是克隆传播与对唑类抗真菌药物具有交叉耐药性的光滑假丝酵母菌的出现相关。
Kaohsiung J Med Sci. 2012 Jun;28(6):306-15. doi: 10.1016/j.kjms.2011.11.011. Epub 2012 Apr 4.
10
Anidulafungin, a new echinocandin: in vitro activity.阿尼芬净，一种新型棘白菌素：体外活性。
Drugs. 2009;69 Suppl 1:91-4. doi: 10.2165/11315560-000000000-00000.
本文引用的文献
1
Posaconazole activity against Candida glabrata after exposure to caspofungin or amphotericin B.泊沙康唑在暴露于卡泊芬净或两性霉素B后对光滑念珠菌的活性。
Antimicrob Agents Chemother. 2008 Feb;52(2):513-7. doi: 10.1128/AAC.01447-07. Epub 2007 Dec 3.
2
In vitro susceptibility of invasive isolates of Candida spp. to anidulafungin, caspofungin, and micafungin: six years of global surveillance.念珠菌属侵袭性分离株对阿尼芬净、卡泊芬净和米卡芬净的体外敏感性：六年全球监测
J Clin Microbiol. 2008 Jan;46(1):150-6. doi: 10.1128/JCM.01901-07. Epub 2007 Nov 21.
3
Results from the ARTEMIS DISK Global Antifungal Surveillance study, 1997 to 2005: an 8.5-year analysis of susceptibilities of Candida species and other yeast species to fluconazole and voriconazole determined by CLSI standardized disk diffusion testing.1997年至2005年ARTEMIS DISK全球抗真菌监测研究结果：一项对念珠菌属及其他酵母菌种对氟康唑和伏立康唑敏感性的8.5年分析，采用CLSI标准化纸片扩散法检测。
J Clin Microbiol. 2007 Jun;45(6):1735-45. doi: 10.1128/JCM.00409-07. Epub 2007 Apr 18.
4
Epidemiology of invasive candidiasis: a persistent public health problem.侵袭性念珠菌病的流行病学：一个持续存在的公共卫生问题。
Clin Microbiol Rev. 2007 Jan;20(1):133-63. doi: 10.1128/CMR.00029-06.
5
In vitro activities of posaconazole, fluconazole, itraconazole, voriconazole, and amphotericin B against a large collection of clinically important molds and yeasts.泊沙康唑、氟康唑、伊曲康唑、伏立康唑和两性霉素B对大量临床重要霉菌和酵母菌的体外活性。
Antimicrob Agents Chemother. 2006 Jun;50(6):2009-15. doi: 10.1128/AAC.00163-06.
6
Clinical significance of azole antifungal drug cross-resistance in Candida glabrata.光滑念珠菌中唑类抗真菌药物交叉耐药的临床意义
J Clin Microbiol. 2006 May;44(5):1740-3. doi: 10.1128/JCM.44.5.1740-1743.2006.
7
Interpretive breakpoints for fluconazole and Candida revisited: a blueprint for the future of antifungal susceptibility testing.氟康唑与念珠菌的解释性折点再探讨：抗真菌药敏试验未来的蓝图。
Clin Microbiol Rev. 2006 Apr;19(2):435-47. doi: 10.1128/CMR.19.2.435-447.2006.
8
Phenotypic switching in Candida lusitaniae on copper sulfate indicator agar: association with amphotericin B resistance and filamentation.葡萄牙念珠菌在硫酸铜指示琼脂上的表型转换：与两性霉素B耐药性及丝状化的关联
J Clin Microbiol. 2006 Apr;44(4):1536-9. doi: 10.1128/JCM.44.4.1536-1539.2006.
9
Correlation of MIC with outcome for Candida species tested against voriconazole: analysis and proposal for interpretive breakpoints.针对念珠菌属对伏立康唑的药敏试验，最小抑菌浓度（MIC）与结果的相关性分析及解释性折点建议
J Clin Microbiol. 2006 Mar;44(3):819-26. doi: 10.1128/JCM.44.3.819-826.2006.
10
Head-to-head comparison of the activities of currently available antifungal agents against 3,378 Spanish clinical isolates of yeasts and filamentous fungi.目前可用抗真菌药物对3378株西班牙临床分离酵母和丝状真菌活性的直接比较。
Antimicrob Agents Chemother. 2006 Mar;50(3):917-21. doi: 10.1128/AAC.50.3.917-921.2006.
Zotero 插件